Shasqi
ActiveTargeting Cancer with Click Chemistry
What it does
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
Next to it in Healthcare and bio · Click chemistry cancer therapeutics
- 株式会社FerroptoCurePlug and Play
FerroptoCure specializes in ferroptosis research and the development of effective therapeutic drugs to treat cancer and other diseases.
- Avenda HealthPlug and Play
Avenda Health offers Unfold AI, an FDA-cleared platform that generates patient-specific 3D cancer maps to aid urologists in planning and executing personalized prostate cancer treatments.
- コウソミル株式会社Plug and Play
Cosomil is a pharmaceutical company that researches and develops methods for diagnosing early-stage diseases like cancer.
- Dimension InxPlug and Play
Dimension Inx is a regenerative therapeutics company. We design and develop therapeutic products that restore tissue and organ function.
- OralomePlug and Play
Advanced precision medicine developer.
- Regcell Co., Ltd.Plug and Play
Regcell is a university-originated venture company and aims to develop novel immunotherapies for immunological diseases and cancer by targeting regulatory T cells, which are specialized for immune suppression.
- Tradewind BioScienceY Combinator W18
Tradewind translates scientific insight into innovative ways of…
- Cell Reserves IncSOSV SOSV IndieBio RebelBio 03
Developing novel protein and peptide-based therapeutics for the treatment of diseases